New Clinical Trial Reporting Requirements

In an effort to streamline clinical trial processes, and make the results of trials more transparent and accessible to the public, The Department of Health and Human Services (HHS) has recently issued a Final Rule which sets out new clinical trial reporting requirements. ...Read More

By |2021-03-15T12:01:49+00:00October 31st, 2016|Big Pharma|

Biosimilars in the US

Biosimilars have become a hot topic recently, with drug prices soaring in the US and patients calling for cheaper alternatives to the brand name drugs that they are forced to buy. But the US is behind when it comes to biosimilars ...Read More

By |2021-03-15T12:02:01+00:00October 19th, 2016|Reference Listed Drug|

The 21st Century Cures Act

Approved by the House of Representatives last year, the 21st Century Cures Act is currently being considered by the US Senate. It seems to have been the topic of much discussion over the past couple of months ...Read More

By |2021-03-15T12:02:36+00:00October 11th, 2016|Big Pharma|
Go to Top